Cargando…

Development and Characterization of In Situ Oral Gel of Spiramycin

The present investigation deals with the optimization, formulation, and characterization of oral in situ gel of spiramycin. Sodium alginate and hydroxypropyl methylcellulose were used as cross-linking and viscosifying agents, respectively. Sodium bicarbonate was used as a floating agent. In preformu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Avinash, Sharma, Jyoti, Kaur, Rupinder, Saini, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094871/
https://www.ncbi.nlm.nih.gov/pubmed/25050376
http://dx.doi.org/10.1155/2014/876182
_version_ 1782325911137288192
author Sharma, Avinash
Sharma, Jyoti
Kaur, Rupinder
Saini, Vinay
author_facet Sharma, Avinash
Sharma, Jyoti
Kaur, Rupinder
Saini, Vinay
author_sort Sharma, Avinash
collection PubMed
description The present investigation deals with the optimization, formulation, and characterization of oral in situ gel of spiramycin. Sodium alginate and hydroxypropyl methylcellulose were used as cross-linking and viscosifying agents, respectively. Sodium bicarbonate was used as a floating agent. In preformulation studies, the melting point, pH, and partition coefficient were found to be 133°C, 9.5, and 0.193, respectively. The drug had retention time at around 2.65 minutes in high performance liquid chromatography (HPLC). During compatibility studies of drug with all polymers, we observed that there were no changes in the FTIR spectra of a mixture of drug and polymers. All the formulations showed good pourability. Floating time and total floating time were ~30 sec and >12 hours, respectively. During in vitro drug release studies, the drug was released from the formulation around 80–100% for 12–16 hrs. In TEM analysis, we found that the drug molecules were well entrapped in the polymer and the drug was released slowly for up to 12 hrs. In these studies, we found that the concentration of sodium alginate and HPMC had significant influence on floating lag time, gelling capacity, and cumulative percentage drug release. During antimicrobial studies, we found that the formulation containing spiramycin showed good zone of inhibition against different microbial strains (Staphylococcus aureus and Escherichia coli).
format Online
Article
Text
id pubmed-4094871
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40948712014-07-21 Development and Characterization of In Situ Oral Gel of Spiramycin Sharma, Avinash Sharma, Jyoti Kaur, Rupinder Saini, Vinay Biomed Res Int Research Article The present investigation deals with the optimization, formulation, and characterization of oral in situ gel of spiramycin. Sodium alginate and hydroxypropyl methylcellulose were used as cross-linking and viscosifying agents, respectively. Sodium bicarbonate was used as a floating agent. In preformulation studies, the melting point, pH, and partition coefficient were found to be 133°C, 9.5, and 0.193, respectively. The drug had retention time at around 2.65 minutes in high performance liquid chromatography (HPLC). During compatibility studies of drug with all polymers, we observed that there were no changes in the FTIR spectra of a mixture of drug and polymers. All the formulations showed good pourability. Floating time and total floating time were ~30 sec and >12 hours, respectively. During in vitro drug release studies, the drug was released from the formulation around 80–100% for 12–16 hrs. In TEM analysis, we found that the drug molecules were well entrapped in the polymer and the drug was released slowly for up to 12 hrs. In these studies, we found that the concentration of sodium alginate and HPMC had significant influence on floating lag time, gelling capacity, and cumulative percentage drug release. During antimicrobial studies, we found that the formulation containing spiramycin showed good zone of inhibition against different microbial strains (Staphylococcus aureus and Escherichia coli). Hindawi Publishing Corporation 2014 2014-06-24 /pmc/articles/PMC4094871/ /pubmed/25050376 http://dx.doi.org/10.1155/2014/876182 Text en Copyright © 2014 Avinash Sharma et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sharma, Avinash
Sharma, Jyoti
Kaur, Rupinder
Saini, Vinay
Development and Characterization of In Situ Oral Gel of Spiramycin
title Development and Characterization of In Situ Oral Gel of Spiramycin
title_full Development and Characterization of In Situ Oral Gel of Spiramycin
title_fullStr Development and Characterization of In Situ Oral Gel of Spiramycin
title_full_unstemmed Development and Characterization of In Situ Oral Gel of Spiramycin
title_short Development and Characterization of In Situ Oral Gel of Spiramycin
title_sort development and characterization of in situ oral gel of spiramycin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094871/
https://www.ncbi.nlm.nih.gov/pubmed/25050376
http://dx.doi.org/10.1155/2014/876182
work_keys_str_mv AT sharmaavinash developmentandcharacterizationofinsituoralgelofspiramycin
AT sharmajyoti developmentandcharacterizationofinsituoralgelofspiramycin
AT kaurrupinder developmentandcharacterizationofinsituoralgelofspiramycin
AT sainivinay developmentandcharacterizationofinsituoralgelofspiramycin